99 related articles for article (PubMed ID: 872076)
1. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
Noonan FP; Halliday WJ; Wall DR; Clunie GJ
Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ; Maluish AE; Stephenson PM; Davis NC
Cancer Res; 1977 Jul; 37(7 Pt 1):1962-71. PubMed ID: 67885
[TBL] [Abstract][Full Text] [Related]
3. Historical background and aspects of the mechanism of leukocyte adherence inhibition.
Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):558-63. PubMed ID: 367582
[TBL] [Abstract][Full Text] [Related]
4. The cell-mediated immunity in patients with malignant melanoma.
Fixa B; Komárková O; Kraus Z; Simková H
Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
[TBL] [Abstract][Full Text] [Related]
5. Immunological response in patients receiving Corynebacterium parvum therapy.
Osborn DE; Castro JE
Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
[No Abstract] [Full Text] [Related]
6. [Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction].
Grishchenko AM; Grinevich IuA; Alferov AN; Redkousova SF; Sen'ko LN
Vrach Delo; 1978 Aug; (8):28-32. PubMed ID: 695500
[No Abstract] [Full Text] [Related]
7. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
Fisher B; Hanlon J; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Jan; 38(1):38-41. PubMed ID: 618581
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
9. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
10. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
Mallmann P; Krebs D
Methods Find Exp Clin Pharmacol; 1990 Jun; 12(5):333-40. PubMed ID: 2232966
[TBL] [Abstract][Full Text] [Related]
11. In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy.
Urist MM; Boddie AW; Townsend CM; Holmes EC
J Thorac Cardiovasc Surg; 1977 Feb; 73(2):189-94. PubMed ID: 834057
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate.
Ablin RJ; Bhatti RA; Guinan PD
Cancer Res; 1978 Nov; 38(11 Pt 1):3702-6. PubMed ID: 698929
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated immunity and serum blocking by radioisotopic leukocyte adherence inhibition assay.
Tsang PH; Holland JF; Bekesi JG
Mt Sinai J Med; 1985 Mar; 52(3):193-200. PubMed ID: 3887140
[No Abstract] [Full Text] [Related]
14. [Stimulation of cellular immunity in patients with malignant tumors].
Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
[No Abstract] [Full Text] [Related]
15. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms].
Scheinberg MA; Sartori JP; de Pinho JG
AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598
[No Abstract] [Full Text] [Related]
18. Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC; Berek JS; Obrist R; Griffiths CT; Berkowitz RS; Hacker NF; Parker L; Lagasse LD; Knapp RC
Cancer Res; 1983 Mar; 43(3):1395-401. PubMed ID: 6825108
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity and blocking factor in ovarian carcinoma.
Mitchell MS; Kohorn EI
Obstet Gynecol; 1976 Nov; 48(5):590-7. PubMed ID: 980285
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
